 David Nesbitt
Concepts (272)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Riboswitch | 15 | 2025 | 63 | 7.190 |
Why?
| | Thermodynamics | 25 | 2025 | 426 | 5.200 |
Why?
| | Nucleic Acid Conformation | 30 | 2025 | 726 | 4.980 |
Why?
| | Fluorescence Resonance Energy Transfer | 20 | 2025 | 178 | 4.470 |
Why?
| | RNA Folding | 13 | 2024 | 35 | 4.280 |
Why?
| | RNA | 16 | 2025 | 940 | 3.340 |
Why?
| | Kinetics | 29 | 2025 | 1627 | 2.860 |
Why?
| | DNA | 7 | 2025 | 1463 | 2.300 |
Why?
| | Lysine | 7 | 2024 | 302 | 2.150 |
Why?
| | Temperature | 13 | 2025 | 679 | 1.960 |
Why?
| | Quantum Theory | 7 | 2012 | 93 | 1.650 |
Why?
| | Nucleic Acids | 3 | 2021 | 72 | 1.640 |
Why?
| | Manganese | 3 | 2022 | 55 | 1.350 |
Why?
| | Magnesium | 4 | 2019 | 155 | 1.230 |
Why?
| | Aptamers, Nucleotide | 3 | 2023 | 85 | 1.100 |
Why?
| | Bacillus subtilis | 3 | 2024 | 69 | 1.070 |
Why?
| | Surface Plasmon Resonance | 3 | 2012 | 89 | 1.060 |
Why?
| | Entropy | 6 | 2021 | 45 | 1.050 |
Why?
| | Sodium | 5 | 2023 | 197 | 1.040 |
Why?
| | Ligands | 7 | 2023 | 673 | 0.950 |
Why?
| | Amino Acids | 2 | 2020 | 521 | 0.920 |
Why?
| | Nanotechnology | 2 | 2021 | 126 | 0.900 |
Why?
| | Thermotoga maritima | 1 | 2024 | 12 | 0.860 |
Why?
| | Base Sequence | 12 | 2024 | 2190 | 0.850 |
Why?
| | G-Quadruplexes | 1 | 2023 | 25 | 0.780 |
Why?
| | Metal Nanoparticles | 2 | 2012 | 85 | 0.700 |
Why?
| | Quantum Dots | 2 | 2013 | 39 | 0.680 |
Why?
| | Gold | 2 | 2012 | 115 | 0.670 |
Why?
| | Molecular Dynamics Simulation | 3 | 2012 | 259 | 0.660 |
Why?
| | Osmotic Pressure | 1 | 2020 | 39 | 0.640 |
Why?
| | Hot Temperature | 2 | 2021 | 407 | 0.640 |
Why?
| | Vinyl Compounds | 2 | 2012 | 5 | 0.640 |
Why?
| | Gases | 3 | 2010 | 53 | 0.620 |
Why?
| | Bromovirus | 2 | 2018 | 4 | 0.610 |
Why?
| | Carbon Dioxide | 2 | 2012 | 242 | 0.580 |
Why?
| | Models, Molecular | 7 | 2023 | 1618 | 0.560 |
Why?
| | Molecular Conformation | 5 | 2021 | 148 | 0.520 |
Why?
| | DNA Primers | 1 | 2018 | 512 | 0.510 |
Why?
| | Oligodeoxyribonucleotides | 2 | 2014 | 141 | 0.480 |
Why?
| | Potassium | 3 | 2023 | 152 | 0.460 |
Why?
| | Diffusion | 4 | 2018 | 121 | 0.450 |
Why?
| | Spectrophotometry, Infrared | 3 | 2011 | 55 | 0.450 |
Why?
| | Cognitive Dysfunction | 4 | 2023 | 461 | 0.440 |
Why?
| | Osmosis | 1 | 2015 | 20 | 0.440 |
Why?
| | Vibration | 4 | 2012 | 71 | 0.440 |
Why?
| | Microscopy, Confocal | 2 | 2014 | 321 | 0.440 |
Why?
| | Supranuclear Palsy, Progressive | 3 | 2025 | 18 | 0.420 |
Why?
| | Hydroxocobalamin | 1 | 2014 | 33 | 0.420 |
Why?
| | Pressure | 3 | 2025 | 225 | 0.410 |
Why?
| | Infrared Rays | 1 | 2014 | 27 | 0.410 |
Why?
| | Cations | 4 | 2020 | 82 | 0.410 |
Why?
| | Urea | 1 | 2014 | 84 | 0.400 |
Why?
| | Selenium Compounds | 1 | 2013 | 18 | 0.400 |
Why?
| | Nucleotide Motifs | 1 | 2013 | 36 | 0.400 |
Why?
| | Cadmium Compounds | 1 | 2013 | 31 | 0.400 |
Why?
| | DNA, Single-Stranded | 1 | 2013 | 119 | 0.370 |
Why?
| | Nanostructures | 1 | 2013 | 117 | 0.370 |
Why?
| | Silver | 1 | 2012 | 38 | 0.360 |
Why?
| | Anions | 1 | 2012 | 31 | 0.360 |
Why?
| | Microscopy, Fluorescence | 1 | 2014 | 416 | 0.360 |
Why?
| | RNA, Viral | 1 | 2015 | 688 | 0.350 |
Why?
| | Telomerase | 1 | 2014 | 248 | 0.350 |
Why?
| | gamma-Aminobutyric Acid | 2 | 2025 | 192 | 0.350 |
Why?
| | Microscopy, Polarization | 1 | 2011 | 31 | 0.340 |
Why?
| | Frontotemporal Dementia | 2 | 2022 | 57 | 0.340 |
Why?
| | Particle Size | 4 | 2013 | 411 | 0.330 |
Why?
| | Nanotubes | 1 | 2011 | 48 | 0.330 |
Why?
| | Alkynes | 1 | 2011 | 66 | 0.330 |
Why?
| | Imidazoles | 1 | 2012 | 254 | 0.320 |
Why?
| | Inverted Repeat Sequences | 2 | 2020 | 18 | 0.320 |
Why?
| | Nerve Net | 4 | 2021 | 285 | 0.320 |
Why?
| | Ethers | 1 | 2010 | 19 | 0.310 |
Why?
| | Nucleic Acid Hybridization | 2 | 2020 | 187 | 0.310 |
Why?
| | Surface Properties | 4 | 2012 | 410 | 0.300 |
Why?
| | Magnetoencephalography | 7 | 2025 | 160 | 0.300 |
Why?
| | Cations, Monovalent | 2 | 2023 | 6 | 0.290 |
Why?
| | Squalene | 1 | 2008 | 8 | 0.290 |
Why?
| | Fluorine | 1 | 2008 | 17 | 0.290 |
Why?
| | Carbocyanines | 3 | 2019 | 36 | 0.290 |
Why?
| | Radiometry | 1 | 2009 | 56 | 0.290 |
Why?
| | Models, Neurological | 2 | 2021 | 254 | 0.280 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2008 | 85 | 0.270 |
Why?
| | Fluorocarbons | 1 | 2010 | 143 | 0.270 |
Why?
| | Phenols | 1 | 2008 | 114 | 0.270 |
Why?
| | Ions | 2 | 2022 | 71 | 0.260 |
Why?
| | Proteins | 2 | 2014 | 1021 | 0.260 |
Why?
| | Photons | 3 | 2012 | 76 | 0.250 |
Why?
| | Base Pairing | 2 | 2019 | 65 | 0.250 |
Why?
| | Protein Folding | 2 | 2021 | 279 | 0.250 |
Why?
| | Materials Testing | 3 | 2012 | 354 | 0.240 |
Why?
| | Spectrum Analysis | 3 | 2023 | 93 | 0.240 |
Why?
| | Free Radicals | 3 | 2012 | 110 | 0.230 |
Why?
| | Polymers | 1 | 2010 | 499 | 0.230 |
Why?
| | Alzheimer Disease | 2 | 2022 | 621 | 0.230 |
Why?
| | Models, Theoretical | 1 | 2009 | 582 | 0.220 |
Why?
| | Frontotemporal Lobar Degeneration | 1 | 2025 | 19 | 0.220 |
Why?
| | Breath Tests | 2 | 2023 | 79 | 0.220 |
Why?
| | Fluorescent Dyes | 2 | 2019 | 329 | 0.220 |
Why?
| | Beta Rhythm | 1 | 2025 | 33 | 0.220 |
Why?
| | Algorithms | 2 | 2012 | 1837 | 0.210 |
Why?
| | Rotation | 3 | 2010 | 121 | 0.210 |
Why?
| | Nucleic Acid Denaturation | 2 | 2014 | 32 | 0.210 |
Why?
| | Fluorescence | 2 | 2015 | 161 | 0.200 |
Why?
| | Dissociative Disorders | 2 | 2014 | 30 | 0.200 |
Why?
| | Electromagnetic Fields | 2 | 2012 | 37 | 0.190 |
Why?
| | Electrons | 2 | 2012 | 88 | 0.180 |
Why?
| | Single Molecule Imaging | 1 | 2022 | 46 | 0.180 |
Why?
| | Calorimetry, Differential Scanning | 1 | 2021 | 37 | 0.170 |
Why?
| | Calorimetry | 1 | 2021 | 72 | 0.170 |
Why?
| | Hydrogen Bonding | 2 | 2019 | 169 | 0.170 |
Why?
| | Cognitive Aging | 1 | 2021 | 18 | 0.170 |
Why?
| | Stereoisomerism | 2 | 2012 | 104 | 0.170 |
Why?
| | Hydrostatic Pressure | 1 | 2020 | 30 | 0.160 |
Why?
| | Polymorphism, Genetic | 1 | 2023 | 612 | 0.160 |
Why?
| | Cobalt | 1 | 2020 | 53 | 0.160 |
Why?
| | Nickel | 1 | 2020 | 64 | 0.160 |
Why?
| | Hydroxyl Radical | 2 | 2018 | 95 | 0.150 |
Why?
| | Auditory Cortex | 1 | 2020 | 47 | 0.150 |
Why?
| | Neurodegenerative Diseases | 1 | 2022 | 151 | 0.150 |
Why?
| | Molecular Sequence Data | 4 | 2015 | 2930 | 0.150 |
Why?
| | Brain | 3 | 2022 | 2933 | 0.140 |
Why?
| | Friction | 1 | 2018 | 13 | 0.140 |
Why?
| | Cognition Disorders | 1 | 2023 | 538 | 0.140 |
Why?
| | Frontal Lobe | 1 | 2020 | 160 | 0.140 |
Why?
| | Viscosity | 1 | 2018 | 90 | 0.140 |
Why?
| | Frailty | 1 | 2022 | 198 | 0.140 |
Why?
| | Tetrahymena | 2 | 2009 | 158 | 0.140 |
Why?
| | Chemistry Techniques, Synthetic | 1 | 2018 | 15 | 0.140 |
Why?
| | Healthy Aging | 1 | 2018 | 40 | 0.140 |
Why?
| | Cerebral Cortex | 1 | 2021 | 464 | 0.130 |
Why?
| | Staining and Labeling | 1 | 2018 | 151 | 0.130 |
Why?
| | Nucleotides | 1 | 2018 | 128 | 0.130 |
Why?
| | Arginine | 1 | 2018 | 262 | 0.130 |
Why?
| | White Matter | 1 | 2018 | 153 | 0.120 |
Why?
| | Coenzymes | 1 | 2016 | 19 | 0.120 |
Why?
| | Lasers | 2 | 2023 | 132 | 0.110 |
Why?
| | Vitamin B 12 | 1 | 2016 | 127 | 0.110 |
Why?
| | Sensitivity and Specificity | 3 | 2023 | 1985 | 0.110 |
Why?
| | Neural Pathways | 1 | 2017 | 311 | 0.110 |
Why?
| | Isotope Labeling | 1 | 2015 | 82 | 0.110 |
Why?
| | Metals | 1 | 2015 | 142 | 0.110 |
Why?
| | RNA, Transfer | 1 | 2015 | 144 | 0.110 |
Why?
| | Immobilized Nucleic Acids | 1 | 2014 | 1 | 0.110 |
Why?
| | Zinc Compounds | 1 | 2013 | 8 | 0.100 |
Why?
| | Solutions | 1 | 2014 | 166 | 0.100 |
Why?
| | Digestive System Surgical Procedures | 1 | 2014 | 109 | 0.100 |
Why?
| | Computer Simulation | 2 | 2009 | 1025 | 0.100 |
Why?
| | Brain Mapping | 1 | 2017 | 536 | 0.100 |
Why?
| | Corpus Callosum | 1 | 2013 | 72 | 0.100 |
Why?
| | Rectal Neoplasms | 1 | 2014 | 156 | 0.100 |
Why?
| | Minimally Invasive Surgical Procedures | 1 | 2014 | 192 | 0.100 |
Why?
| | Protein Biosynthesis | 1 | 2016 | 458 | 0.100 |
Why?
| | Aging | 2 | 2022 | 1966 | 0.090 |
Why?
| | Sulfides | 1 | 2013 | 91 | 0.090 |
Why?
| | Scattering, Radiation | 1 | 2012 | 103 | 0.090 |
Why?
| | Cognition | 1 | 2021 | 1266 | 0.090 |
Why?
| | Transcription, Genetic | 2 | 2016 | 1496 | 0.090 |
Why?
| | Hydrogen | 1 | 2012 | 73 | 0.090 |
Why?
| | Transition Temperature | 1 | 2012 | 29 | 0.090 |
Why?
| | Atrophy | 2 | 2023 | 201 | 0.090 |
Why?
| | Oligoribonucleotides | 1 | 2012 | 52 | 0.090 |
Why?
| | Robotic Surgical Procedures | 1 | 2014 | 182 | 0.090 |
Why?
| | Energy Transfer | 1 | 2012 | 49 | 0.090 |
Why?
| | RNA, Bacterial | 1 | 2012 | 189 | 0.090 |
Why?
| | GABA Uptake Inhibitors | 2 | 2021 | 5 | 0.080 |
Why?
| | Bipolar Disorder | 1 | 2013 | 280 | 0.080 |
Why?
| | Macromolecular Substances | 1 | 2011 | 224 | 0.080 |
Why?
| | Neurons | 1 | 2020 | 1640 | 0.080 |
Why?
| | Onium Compounds | 1 | 2010 | 8 | 0.080 |
Why?
| | Parkinson Disease | 1 | 2017 | 600 | 0.080 |
Why?
| | Magnetic Resonance Imaging | 5 | 2022 | 3863 | 0.080 |
Why?
| | Water | 1 | 2012 | 469 | 0.070 |
Why?
| | Absorption | 1 | 2008 | 60 | 0.070 |
Why?
| | Binding Sites | 1 | 2012 | 1329 | 0.070 |
Why?
| | Aged | 7 | 2025 | 25913 | 0.070 |
Why?
| | Least-Squares Analysis | 1 | 2008 | 76 | 0.070 |
Why?
| | RNA, Messenger | 2 | 2016 | 2832 | 0.070 |
Why?
| | Static Electricity | 1 | 2008 | 113 | 0.070 |
Why?
| | Cross-Over Studies | 2 | 2021 | 601 | 0.070 |
Why?
| | RNA, Catalytic | 1 | 2009 | 189 | 0.070 |
Why?
| | Phase Transition | 1 | 2008 | 26 | 0.070 |
Why?
| | Humans | 15 | 2025 | 144759 | 0.070 |
Why?
| | Sulfonamides | 1 | 2012 | 580 | 0.070 |
Why?
| | Equipment Failure Analysis | 1 | 2008 | 128 | 0.070 |
Why?
| | Adenocarcinoma | 1 | 2014 | 928 | 0.070 |
Why?
| | Molecular Structure | 1 | 2008 | 499 | 0.060 |
Why?
| | Aged, 80 and over | 4 | 2022 | 8265 | 0.060 |
Why?
| | Models, Chemical | 1 | 2008 | 269 | 0.060 |
Why?
| | Time Factors | 3 | 2014 | 7173 | 0.060 |
Why?
| | Cardiovascular Diseases | 1 | 2018 | 2168 | 0.060 |
Why?
| | Equipment Design | 1 | 2008 | 530 | 0.060 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2021 | 630 | 0.060 |
Why?
| | Double-Blind Method | 2 | 2021 | 2029 | 0.060 |
Why?
| | Middle Aged | 7 | 2025 | 35875 | 0.050 |
Why?
| | Cohort Studies | 3 | 2021 | 5960 | 0.050 |
Why?
| | Male | 9 | 2025 | 72315 | 0.050 |
Why?
| | Female | 9 | 2025 | 78271 | 0.050 |
Why?
| | Protein Binding | 1 | 2009 | 2273 | 0.050 |
Why?
| | Postoperative Complications | 1 | 2014 | 2919 | 0.040 |
Why?
| | Prefrontal Cortex | 1 | 2025 | 328 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2023 | 433 | 0.040 |
Why?
| | Syndrome | 1 | 2022 | 380 | 0.040 |
Why?
| | Markov Chains | 1 | 2021 | 129 | 0.040 |
Why?
| | Choroid | 1 | 2001 | 80 | 0.040 |
Why?
| | Rest | 1 | 2021 | 124 | 0.040 |
Why?
| | Executive Function | 1 | 2025 | 461 | 0.040 |
Why?
| | Neuroimaging | 1 | 2022 | 289 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2008 | 3409 | 0.040 |
Why?
| | Neovascularization, Pathologic | 1 | 2001 | 286 | 0.040 |
Why?
| | Angiogenesis Inhibitors | 1 | 2001 | 237 | 0.040 |
Why?
| | Synaptic Transmission | 1 | 2021 | 290 | 0.040 |
Why?
| | Genetic Therapy | 1 | 2001 | 313 | 0.040 |
Why?
| | Collagen | 1 | 2001 | 456 | 0.040 |
Why?
| | Electroencephalography | 1 | 2022 | 532 | 0.040 |
Why?
| | Uracil | 1 | 2018 | 36 | 0.030 |
Why?
| | Isotopes | 1 | 2018 | 34 | 0.030 |
Why?
| | Biotin | 1 | 2018 | 32 | 0.030 |
Why?
| | Peptide Fragments | 1 | 2001 | 699 | 0.030 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2018 | 154 | 0.030 |
Why?
| | Young Adult | 3 | 2021 | 14105 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2017 | 427 | 0.030 |
Why?
| | Templates, Genetic | 1 | 2015 | 63 | 0.030 |
Why?
| | Automation | 1 | 2015 | 102 | 0.030 |
Why?
| | Heart Rate | 1 | 2018 | 855 | 0.030 |
Why?
| | Adolescent | 3 | 2021 | 22428 | 0.030 |
Why?
| | Lithium Compounds | 1 | 2013 | 11 | 0.030 |
Why?
| | Antimanic Agents | 1 | 2013 | 19 | 0.030 |
Why?
| | Robotics | 1 | 2015 | 87 | 0.030 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2013 | 47 | 0.030 |
Why?
| | In Vitro Techniques | 1 | 2015 | 1047 | 0.020 |
Why?
| | Biosensing Techniques | 1 | 2015 | 139 | 0.020 |
Why?
| | Adenine | 1 | 2015 | 339 | 0.020 |
Why?
| | Risk Factors | 2 | 2018 | 10779 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2017 | 780 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2017 | 1134 | 0.020 |
Why?
| | Blood Pressure | 1 | 2018 | 1769 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2013 | 541 | 0.020 |
Why?
| | Oxygen | 1 | 2017 | 995 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2014 | 1462 | 0.020 |
Why?
| | Adult | 3 | 2021 | 40449 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2014 | 1095 | 0.020 |
Why?
| | Laparoscopy | 1 | 2014 | 475 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 4271 | 0.020 |
Why?
| | Body Mass Index | 1 | 2018 | 2438 | 0.020 |
Why?
| | Length of Stay | 1 | 2014 | 1337 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2925 | 0.020 |
Why?
| | Sex Characteristics | 1 | 2013 | 790 | 0.020 |
Why?
| | Animals | 2 | 2008 | 38058 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5868 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2016 | 2608 | 0.020 |
Why?
| | Exercise | 1 | 2018 | 2201 | 0.020 |
Why?
| | Age Factors | 1 | 2013 | 3333 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2013 | 3604 | 0.010 |
Why?
| | Prognosis | 1 | 2014 | 4282 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2014 | 5408 | 0.010 |
Why?
| | Oligonucleotides | 1 | 2006 | 151 | 0.010 |
Why?
| | Endostatins | 1 | 2001 | 10 | 0.010 |
Why?
| | Ocular Physiological Phenomena | 1 | 2001 | 10 | 0.010 |
Why?
| | Collagen Type XVIII | 1 | 2001 | 5 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2006 | 2027 | 0.010 |
Why?
| | Injections, Intravenous | 1 | 2001 | 200 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2001 | 275 | 0.010 |
Why?
| | Adenoviridae | 1 | 2001 | 199 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 2001 | 205 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2001 | 337 | 0.010 |
Why?
| | Models, Biological | 1 | 2006 | 1821 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2014 | 17066 | 0.010 |
Why?
| | Gene Expression | 1 | 2001 | 1490 | 0.010 |
Why?
| | Child | 1 | 2013 | 22633 | 0.010 |
Why?
| | Liver | 1 | 2001 | 1887 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2001 | 5992 | 0.000 |
Why?
| | Mice | 1 | 2001 | 18339 | 0.000 |
Why?
|
|
Nesbitt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|